SARS CoV-2 neutralizing antibodies (nAb) are specialized antibodies that block SARS CoV-2 from binding to our cells. SARS CoV-2 vaccines ultimately aim to incite growth of neutralizing antibodies to develop acquired immunity in patients. 

 Optical Q SARS CoV-2 nAb detection kit is a breakthrough fluorescence immunoassay (FIA) solution that can quantitatively measure neutralizing antibodies in blood samples within 15 minutes. This breakthrough test kit will allow for:

* Evaluating vaccine efficacy by detecting SARS-CoV-2 neutralizing
antibodies in the serum from vaccinated patients;

* Monitoring immunization by mass detecting SARS-CoV-2 neutralizing
antibodies in serum of recovering COVID-19 patients.